Christopher R. Stone

Array ( [id] => 10925812 [patent_doc_number] => 20140328834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/284240 [patent_app_country] => US [patent_app_date] => 2014-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15904 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14284240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10743201 [patent_doc_number] => 20160089352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-31 [patent_title] => 'CELL MEMBRANE TRANSPORT PROMOTER FOR SELECTIVE 5-HT1A SEROTONIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/891944 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5505 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10209331 [patent_doc_number] => 20150094321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'COMBINATION' [patent_app_type] => utility [patent_app_number] => 14/270774 [patent_app_country] => US [patent_app_date] => 2014-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20098 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10978364 [patent_doc_number] => 20160175308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'THERAPEUTIC AGENTS FOR MODULATING THYMIC FUNCTION AND/OR GROWTH AND/OR TREATING VARIOUS DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/786653 [patent_app_country] => US [patent_app_date] => 2014-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11452 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10699352 [patent_doc_number] => 20160045499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'MINOXIDIL FOR SUPPRESSING ANDROGEN RECEPTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 14/783544 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5904 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882567 [patent_doc_number] => 08969333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Therapeutic compositions and methods' [patent_app_type] => utility [patent_app_number] => 14/261783 [patent_app_country] => US [patent_app_date] => 2014-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 30 [patent_no_of_words] => 15712 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14261783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11596783 [patent_doc_number] => 09643933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-09 [patent_title] => 'Compounds useful as antibiotic tolerance inhibitors' [patent_app_type] => utility [patent_app_number] => 14/786345 [patent_app_country] => US [patent_app_date] => 2014-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29467 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721114 [patent_doc_number] => 20160067261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'SERCA INHIBITOR AND CALMODULIN ANTAGONIST COMBINATION' [patent_app_type] => utility [patent_app_number] => 14/785946 [patent_app_country] => US [patent_app_date] => 2014-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13918 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14785946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10398232 [patent_doc_number] => 20150283240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'STABILIZED COMPOSITIONS COMPRISING A THERAPEUTICALLY ACTIVE AGENT AND AN OXIDIZING PRESERVATIVE' [patent_app_type] => utility [patent_app_number] => 14/245014 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3400 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14245014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9635550 [patent_doc_number] => 20140213659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 14/228944 [patent_app_country] => US [patent_app_date] => 2014-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10904 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14228944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721053 [patent_doc_number] => 20160067200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'USES OF 6-AMINOHEXANOIC ACID TO MANAGE BLEEDING CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/779246 [patent_app_country] => US [patent_app_date] => 2014-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4100 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9671752 [patent_doc_number] => 20140235615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'HETEROCYCLIC COMPOUND' [patent_app_type] => utility [patent_app_number] => 14/223329 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118057 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657347 [patent_doc_number] => 20140228352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'HETEROCYCLIC COMPOUND' [patent_app_type] => utility [patent_app_number] => 14/223259 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118058 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656096 [patent_doc_number] => 20160002240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'NUCLEOSIDE ANALOG SALTS WITH IMPROVED SOLUBILITY AND METHODS OF FORMING SAME' [patent_app_type] => utility [patent_app_number] => 14/770655 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14225 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11612535 [patent_doc_number] => 09650381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Compounds useful as inhibitors of ATR kinase' [patent_app_type] => utility [patent_app_number] => 14/201037 [patent_app_country] => US [patent_app_date] => 2014-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 128485 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14201037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662218 [patent_doc_number] => 20160008362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'AGENT FOR PREVENTING AND/OR TREATING OCULAR INFLAMMATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 14/770744 [patent_app_country] => US [patent_app_date] => 2014-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14374 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10663534 [patent_doc_number] => 20160009677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'TRICYCLIC COMPOUND AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/771049 [patent_app_country] => US [patent_app_date] => 2014-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112696 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13222659 [patent_doc_number] => 10125094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-13 [patent_title] => Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B [patent_app_type] => utility [patent_app_number] => 14/771448 [patent_app_country] => US [patent_app_date] => 2014-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11022 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10657706 [patent_doc_number] => 20160003850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE' [patent_app_type] => utility [patent_app_number] => 14/770442 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21605 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9560749 [patent_doc_number] => 20140178463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/187841 [patent_app_country] => US [patent_app_date] => 2014-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21340 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187841 [rel_patent_id] =>[rel_patent_doc_number] =>)